Join ACMG Foundation’s Corporate Partners on Wednesday, March 19, from 12:15–1:15 PM for one-hour lunchtime sessions spotlighting the latest trends, innovations, and developments in genomic medicine. These sessions foster collaboration between industry and genetics professionals, offering insights into cutting-edge technologies and best practices. Open to all attendees, but space is limited. Note: These commercially supported sessions are not eligible for ACMG educational credit. Open to all attendees, pre-registration is required. Session descriptions and links to pre-register coming soon, check back for updates.
ACMG Foundation Corporate Partner Insights Sessions
Natera
Wednesday, March 19, 2025
12:15 PM - 1:15 PM
LA Convention Center
Room 408 A
Precision Medicine across Oncology, Renal Genetics and Reproductive Health
The session will provide insights on how genomic testing in oncology, renal genetics and reproductive health can enable personalized care and improve outcomes. This session will explore:
- how data from molecular residual disease testing can enhance awareness of hereditary cancer testing
- the interaction between the genetic causes of kidney disease and targeted therapies
- how expansion of prenatal screening improves outcomes through early diagnosis and perinatal treatment options
Speakers
Sheetal Parmar, MS CGC, Natera
John Williams III, MD, Cedars-Sinai Medical Center and the David Geffen School of Medicine at UCLA
Katya Brossart, MS, CGC, Natera Organ Health
Eileen Hoffman, MS, CGC, Natera
Registration: coming soon
MyOme Inc.
Wednesday, March 19, 2025
12:15 PM - 1:15 PM
LA Convention Center
Room 403 A
Unlocking Genomics: Advancing Rare Disease Diagnostics
This session will provide insights on the potential of whole genome sequencing (WGS) in rare disease diagnostics. It will provide actionable insights into leveraging WGS to uncover elusive diagnoses while highlighting emerging technologies shaping the future of rare disease care. Topic include:
- Move beyond the genome in the Undiagnosed Disease Network with the GREGoR program
- How to use long-read sequencing as an emergent technology in clinical settings including rare disease
Speakers
Akash Kumar, MD, PhD, Chief Medical and Scientific Officer, MyOme
Danny Miller, MD, PhD, FACMG, Assistant Professor, University of Washington
Stephen Montgomery, PhD, Professor, Stanford University
Registration: coming soon
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
)
)
)
)
){kind=logo}
){kind=logo}
){kind=logo}